As a prominent example, promoter hypermethylation of MutL Homolog 1 (MLH1) is present already in IM, but the hypermethylation does not affect the specific CpG island responsible for its silencing in cancer [57] (Additional file 6: Fig. S6D); MLH1 was not differentially expressed (data not shown). Here, MLH1 is linked to cancer.